The global Oral Tranexamic Acid market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
The “Oral Tranexamic Acid Industry Forecast” looks at past sales and reviews total world Oral Tranexamic Acid sales in 2023, providing a comprehensive analysis by region and market sector of projected Oral Tranexamic Acid sales for 2024 through 2030. With Oral Tranexamic Acid sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Tranexamic Acid industry.
This Insight Report provides a comprehensive analysis of the global Oral Tranexamic Acid landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Tranexamic Acid portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral Tranexamic Acid market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Tranexamic Acid and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Tranexamic Acid.
The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Tranexamic Acid market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Tablets
Capsules
Segmentation by application
Acute Bleeding
Chronic Bleeding
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Daiichi Sankyo
Teva Pharmaceuticals
Hunan Dongting Pharmaceutical
CR Double-Crane
Shanghai Sine Pharmaceutical
Sinopharm Group
China Resources Sanjiu
Key Questions Addressed in this Report
What is the 10-year outlook for the global Oral Tranexamic Acid market?
What factors are driving Oral Tranexamic Acid market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oral Tranexamic Acid market opportunities vary by end market size?
How does Oral Tranexamic Acid break out type, application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oral Tranexamic Acid Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Oral Tranexamic Acid by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Oral Tranexamic Acid by Country/Region, 2019, 2023 & 2030
2.2 Oral Tranexamic Acid Segment by Type
2.2.1 Tablets
2.2.2 Capsules
2.3 Oral Tranexamic Acid Sales by Type
2.3.1 Global Oral Tranexamic Acid Sales Market Share by Type (2019-2024)
2.3.2 Global Oral Tranexamic Acid Revenue and Market Share by Type (2019-2024)
2.3.3 Global Oral Tranexamic Acid Sale Price by Type (2019-2024)
2.4 Oral Tranexamic Acid Segment by Application
2.4.1 Acute Bleeding
2.4.2 Chronic Bleeding
2.4.3 Others
2.5 Oral Tranexamic Acid Sales by Application
2.5.1 Global Oral Tranexamic Acid Sale Market Share by Application (2019-2024)
2.5.2 Global Oral Tranexamic Acid Revenue and Market Share by Application (2019-2024)
2.5.3 Global Oral Tranexamic Acid Sale Price by Application (2019-2024)
3 Global Oral Tranexamic Acid by Company
3.1 Global Oral Tranexamic Acid Breakdown Data by Company
3.1.1 Global Oral Tranexamic Acid Annual Sales by Company (2019-2024)
3.1.2 Global Oral Tranexamic Acid Sales Market Share by Company (2019-2024)
3.2 Global Oral Tranexamic Acid Annual Revenue by Company (2019-2024)
3.2.1 Global Oral Tranexamic Acid Revenue by Company (2019-2024)
3.2.2 Global Oral Tranexamic Acid Revenue Market Share by Company (2019-2024)
3.3 Global Oral Tranexamic Acid Sale Price by Company
3.4 Key Manufacturers Oral Tranexamic Acid Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Tranexamic Acid Product Location Distribution
3.4.2 Players Oral Tranexamic Acid Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Oral Tranexamic Acid by Geographic Region
4.1 World Historic Oral Tranexamic Acid Market Size by Geographic Region (2019-2024)
4.1.1 Global Oral Tranexamic Acid Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Oral Tranexamic Acid Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Oral Tranexamic Acid Market Size by Country/Region (2019-2024)
4.2.1 Global Oral Tranexamic Acid Annual Sales by Country/Region (2019-2024)
4.2.2 Global Oral Tranexamic Acid Annual Revenue by Country/Region (2019-2024)
4.3 Americas Oral Tranexamic Acid Sales Growth
4.4 APAC Oral Tranexamic Acid Sales Growth
4.5 Europe Oral Tranexamic Acid Sales Growth
4.6 Middle East & Africa Oral Tranexamic Acid Sales Growth
5 Americas
5.1 Americas Oral Tranexamic Acid Sales by Country
5.1.1 Americas Oral Tranexamic Acid Sales by Country (2019-2024)
5.1.2 Americas Oral Tranexamic Acid Revenue by Country (2019-2024)
5.2 Americas Oral Tranexamic Acid Sales by Type
5.3 Americas Oral Tranexamic Acid Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Tranexamic Acid Sales by Region
6.1.1 APAC Oral Tranexamic Acid Sales by Region (2019-2024)
6.1.2 APAC Oral Tranexamic Acid Revenue by Region (2019-2024)
6.2 APAC Oral Tranexamic Acid Sales by Type
6.3 APAC Oral Tranexamic Acid Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oral Tranexamic Acid by Country
7.1.1 Europe Oral Tranexamic Acid Sales by Country (2019-2024)
7.1.2 Europe Oral Tranexamic Acid Revenue by Country (2019-2024)
7.2 Europe Oral Tranexamic Acid Sales by Type
7.3 Europe Oral Tranexamic Acid Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oral Tranexamic Acid by Country
8.1.1 Middle East & Africa Oral Tranexamic Acid Sales by Country (2019-2024)
8.1.2 Middle East & Africa Oral Tranexamic Acid Revenue by Country (2019-2024)
8.2 Middle East & Africa Oral Tranexamic Acid Sales by Type
8.3 Middle East & Africa Oral Tranexamic Acid Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Tranexamic Acid
10.3 Manufacturing Process Analysis of Oral Tranexamic Acid
10.4 Industry Chain Structure of Oral Tranexamic Acid
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Tranexamic Acid Distributors
11.3 Oral Tranexamic Acid Customer
12 World Forecast Review for Oral Tranexamic Acid by Geographic Region
12.1 Global Oral Tranexamic Acid Market Size Forecast by Region
12.1.1 Global Oral Tranexamic Acid Forecast by Region (2025-2030)
12.1.2 Global Oral Tranexamic Acid Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oral Tranexamic Acid Forecast by Type
12.7 Global Oral Tranexamic Acid Forecast by Application
13 Key Players Analysis
13.1 Daiichi Sankyo
13.1.1 Daiichi Sankyo Company Information
13.1.2 Daiichi Sankyo Oral Tranexamic Acid Product Portfolios and Specifications
13.1.3 Daiichi Sankyo Oral Tranexamic Acid Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Daiichi Sankyo Main Business Overview
13.1.5 Daiichi Sankyo Latest Developments
13.2 Teva Pharmaceuticals
13.2.1 Teva Pharmaceuticals Company Information
13.2.2 Teva Pharmaceuticals Oral Tranexamic Acid Product Portfolios and Specifications
13.2.3 Teva Pharmaceuticals Oral Tranexamic Acid Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Teva Pharmaceuticals Main Business Overview
13.2.5 Teva Pharmaceuticals Latest Developments
13.3 Hunan Dongting Pharmaceutical
13.3.1 Hunan Dongting Pharmaceutical Company Information
13.3.2 Hunan Dongting Pharmaceutical Oral Tranexamic Acid Product Portfolios and Specifications
13.3.3 Hunan Dongting Pharmaceutical Oral Tranexamic Acid Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Hunan Dongting Pharmaceutical Main Business Overview
13.3.5 Hunan Dongting Pharmaceutical Latest Developments
13.4 CR Double-Crane
13.4.1 CR Double-Crane Company Information
13.4.2 CR Double-Crane Oral Tranexamic Acid Product Portfolios and Specifications
13.4.3 CR Double-Crane Oral Tranexamic Acid Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 CR Double-Crane Main Business Overview
13.4.5 CR Double-Crane Latest Developments
13.5 Shanghai Sine Pharmaceutical
13.5.1 Shanghai Sine Pharmaceutical Company Information
13.5.2 Shanghai Sine Pharmaceutical Oral Tranexamic Acid Product Portfolios and Specifications
13.5.3 Shanghai Sine Pharmaceutical Oral Tranexamic Acid Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Shanghai Sine Pharmaceutical Main Business Overview
13.5.5 Shanghai Sine Pharmaceutical Latest Developments
13.6 Sinopharm Group
13.6.1 Sinopharm Group Company Information
13.6.2 Sinopharm Group Oral Tranexamic Acid Product Portfolios and Specifications
13.6.3 Sinopharm Group Oral Tranexamic Acid Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Sinopharm Group Main Business Overview
13.6.5 Sinopharm Group Latest Developments
13.7 China Resources Sanjiu
13.7.1 China Resources Sanjiu Company Information
13.7.2 China Resources Sanjiu Oral Tranexamic Acid Product Portfolios and Specifications
13.7.3 China Resources Sanjiu Oral Tranexamic Acid Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 China Resources Sanjiu Main Business Overview
13.7.5 China Resources Sanjiu Latest Developments
14 Research Findings and Conclusion
*If Applicable.